Thrombosis Research10.1016/s0049-3848(07)70057-92007119S10012 Haemostatic activation in post-menopausal women taking low dose hormone therapy: less effect with transdermal administration?J.F. Brosnan, B.L. Sheppard, L.A. Norris,
Hormone Research in Paediatrics10.1159/0000235532000533144-147Estrogen Receptors and the Activity of Nitric Oxide Synthase in the Artery of Female Rats Receiving Hormone Replacement TherapySaizhu Wu, Yunjun Ruan, Xiaohu Zhu, Wenyan Lai,
Nitric Oxide10.1016/j.niox.2011.04.0022011244199-203The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosisToshio Hayashi, Koichiro Ina, Morihiko Maeda, Hideki Nomura,
Nitric Oxide10.1016/j.niox.2006.04.204200614462P137. Effect of aerobic exercise on nitric oxide, uric acid, antioxidant activity and oxidative stress in human salivaAntonio Jesus Rodriguez-Malaver, David Gonzalez, Ramón Marquina, Norelis Rondón, Rafael Reyes,
Journal of the American College of Cardiology10.1016/s0735-1097(02)81152-4200239257Effects of low dose hormone replacement therapy on nitric oxide bioactivity and markers of inflammation compared with conventional dose in postmenopausal womenKwang K. Koh, Mi-Seung Shin,
Journal of Women's Health10.1089/1540999033224477012003128723-747Low-Dose Estrogen Therapy for Menopausal Women: A Review of Efficacy and SafetyCarolyn Crandall
Estrogen Therapy10.1159/00040198326-39Application of Cost-Effectiveness Analysis to Post-Menopausal Estrogen TherapyW. H. Utian,
Estrogens in the Post-Menopause10.1159/00039826540-44Post-Menopausal Estrogen ProductionP. K. Siiteri,
Nitric Oxide10.1016/j.niox.2007.09.03120071715A26. A phase I/II pilot trial of low-dose, sustained-release GTN for prostate cancer patients with recurrence after primary therapyD.R. Siemens, J. Heaton, M. Adams, C. Graham,
Ageing and Estrogens10.1159/0003948382-21The Management of the Pre-Menopausal and the Post-Menopausal PatientC. Lauritzen,